Pavel Osmančik, HRS 2019 – Five-year Outcomes from PRAGUE-12
Dr Pavel Osmančik (Senior Physician, Department of Arrhythmology, University Hospital Královské Vinohrady, Prague, Czech Republic) spoke with us at Heart Rhythm 2019 about the Surgical Treatment of Atrial Fibrillation – Prospective Randomized Study (PRAGUE-12). This examined the five-year outcomes in cardiac surgery for patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation.
Filmed at Heart Rhythm 2019, San Francisco, CA, USA.
Speaker’s Disclosures: Pavel Osmančik has nothing to disclose in relation to this video interview.
1. The Surgical Treatment of Atrial Fibrillation – Prospective Randomized Study (PRAGUE-12) examined the impact of the addition of concomitant surgical ablation in patients with atrial fibrillation who were referred for cardiac surgery. What were the initial findings? (0:08)
2. What new evidence has been provided by the recent long-term follow up evaluations? (2:06)
3. What are the current unmet needs in cardiac surgery patients with atrial fibrillation? (2:39)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Atrial Fibrillation
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Søren Zöga Diederichsen, EHRA 2023: NT-proBNP as a tool for atrial fibrillation screening, post hoc analysis of the LOOP study
Recently it has been shown that NT-proBNP may be a useful tool for finding people with an increased risk of atrial fibrillation and stroke. In this touchCARDIO interview, we speak with Dr Søren Zöga Diederichsen (Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark) to discuss the post hoc analysis of the LOOP study. The abstract entitled ‘Atrial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!